About the Uterine Cancer Session
Uterine cancer, predominantly affecting the lining of the uterus, poses significant health challenges for women worldwide. Research in this field encompasses various aspects, from understanding the genetic predispositions to exploring novel treatment modalities. Recent strides in cancer research have uncovered potential biomarkers for early detection and personalized therapies, promising improved outcomes. Additionally, studies focus on elucidating the interplay between hormones, lifestyle factors, and uterine cancer risk, aiding in prevention strategies. Furthermore, innovative immunotherapies and targeted drugs offer hope for advanced-stage patients. Collaborative efforts among researchers, clinicians, and advocates drive progress, emphasizing the importance of early diagnosis, risk assessment, and comprehensive care in combating uterine cancer's burden on women's health.
Topics Covered in Uterine Cancer
Endometrial Carcinoma
Molecular Classification
Obesity & Estrogen Risk
Minimally Invasive Surgery
Sentinel Node Mapping
Checkpoint Immunotherapy
Related Scientific Sessions at CIOC 2027
Why Attend the Uterine Cancer Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Uterine Cancer work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Uterine Cancer research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Uterine Cancer track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Uterine Cancer Conference 2027 — FAQs
What is the Uterine Cancer track at CIOC 2027?
The Uterine Cancer track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Uterine Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Uterine Cancer sessions?
Cancer researchers and clinicians, educators and students with an interest in Uterine Cancer are all welcome — whether presenting or attending.
Can I present my research in the Uterine Cancer track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Uterine Cancer sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Uterine Cancer track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.